Evaluation of the efficiency of serum biotinidase activity as a newborn screening test in Turkey

被引:5
作者
Ercan, Mujgan [1 ]
Akbulut, Emis Deniz [2 ]
Oz, Ozlem [3 ]
Atas, Nurgul [4 ]
Karaca, Meryem [5 ]
Yilmaz, Fatma Meric [6 ]
机构
[1] Harran Univ, Fac Med, Dept Biochem, Mardin Yolu 22 Km Osmanbey Kampusu, TR-63300 Sanliurfa, Turkey
[2] Minist Hlth, Ankara City Hosp, Clin Biochem Lab, Ankara, Turkey
[3] Harran Univ, Fac Med, Dept Med Genet, Sanliurfa, Turkey
[4] Harran Univ, Fac Med, Dept Pediat, Sanliurfa, Turkey
[5] Harran Univ, Fac Med, Dept Pediat Metab Disorders, Sanliurfa, Turkey
[6] Yildirim Beyazit Univ, Fac Med, Dept Biochem, Ankara, Turkey
关键词
biotinidase activity; biotinidase deficiency; newborn screening; sensitivity; specificity; DEFICIENCY;
D O I
10.1515/jpem-2020-0382
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Biotinidase Deficiency (BD) is an autosomal recessive metabolic disorder. However, the relationship between genotype and biochemical phenotype has not been completely elucidated yet. But still, some mutations are accepted to be associated with profound or partial deficiency. We aimed to evaluate the results of biochemical enzyme activity in accordance with the presence of genetic mutations and investigate the correlation between genotype and biochemical phenotype together in the study. Methods: This retrospective study was carried out using data from medical records of 133 infants detected by the newborn screening followed by serum biotinidase activity (BA) detection with semi-quantitative colorimetric method. Mutation analysis was performed to confirm the diagnosis. In addition, the expected biochemical phenotype based on the known mutant alleles were compared with the observed biochemical phenotype. Results: When confirmed with mutation analysis results, the diagnostic sensitivity and specificity of serum BA with spectrophotometric method was 93.1% and 95.1%, respectively. In 93.98% of the cases conformity was observed between the biochemical phenotype and the genotype. The c.1330 G>C(p.D444H) and c.470 G>A (p.Arg157His) were the most common allelic variants with frequencies of 63.69% and 33.75%, respectively. Conclusions: The diagnostic test is supposed to have a high sensitivity to identify asymptomatic BD patients. Apparently healthy cases with almost normal enzyme activity and a variant allele in the genetic analysis were reported to present symptoms under stress conditions, which should be kept in mind. This study can be accepted as an informative report as it may contribute to the literature in terms of the allelic frequency and determination of the relation between genotype and biochemical phenotype. Also, method verification including the assessment of possible effects of non-genetic factors on BA according to the certain mutation types is warranted.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 18 条
[1]   Biotinidase deficiency: Genotype-biochemical phenotype association in Brazilian patients [J].
Borsatto, Taciane ;
Sperb-Ludwig, Fernanda ;
Lima, Samyra E. ;
Carvalho, Maria R. S. ;
Fonseca, Pablo A. S. ;
Camelo, Jose S., Jr. ;
Ribeiro, Erlane M. ;
de Medeiros, Paula F. V. ;
Lourenco, Charles M. ;
de Souza, Carolina F. M. ;
Boy, Raquel ;
Felix, Temis M. ;
Bittar, Camila M. ;
Pinto, Louise L. C. ;
Neto, Eurico C. ;
Blom, Henk J. ;
Schwartz, Ida V. D. .
PLOS ONE, 2017, 12 (05)
[2]   Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients [J].
Borsatto, Taciane ;
Sperb-Ludwig, Fernanda ;
Pinto, Louise L. C. ;
De Luca, Gisele R. ;
Carvalho, Francisca L. ;
De Souza, Carolina F. M. ;
De Medeiros, Paula F. V. ;
Lourenco, Charles M. ;
Filho, Reinaldo L. O. ;
Neto, Eurico C. ;
Bernardi, Pricila ;
Leistner-Segal, Sandra ;
Schwartz, Ida V. D. .
BMC MEDICAL GENETICS, 2014, 15
[3]   Single center experience of biotinidase deficiency: 259 patients and six novel mutations [J].
Canda, Ebru ;
Yazici, Havva ;
Er, Esra ;
Kose, Melis ;
Basol, Gunes ;
Onay, Huseyin ;
Ucar, Sema Kalkan ;
Habif, Sara ;
Ozkinay, Ferda ;
Coker, Mahmut .
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2018, 31 (08) :917-926
[4]   Biotinidase and its roles in biotin metabolism [J].
Hymes, J ;
Wolf, B .
CLINICA CHIMICA ACTA, 1996, 255 (01) :1-11
[5]   Clinical utility gene card for: Biotinidase deficiency [J].
Kuery, Sebastien ;
Ramaekers, Vincent ;
Bezieau, Stephane ;
Wolf, Barry .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2012, 20 (05) :4-4
[6]   Newborn screening for biotinidase deficiency in Brazil: biochemical and molecular characterizations [J].
Neto, EC ;
Schulte, J ;
Rubim, R ;
Lewis, E ;
DeMari, J ;
Castilhos, C ;
Brites, A ;
Giugliani, R ;
Jensen, KP ;
Wolf, B .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2004, 37 (03) :295-299
[7]   Forty-eight novel mutations causing biotinidase deficiency [J].
Procter, Melinda ;
Wolf, Barry ;
Mao, Rong .
MOLECULAR GENETICS AND METABOLISM, 2016, 117 (03) :369-372
[8]  
Strovel Erin T, 2017, Genet Med, V19, DOI 10.1038/gim.2017.84
[9]   Current status of newborn screening worldwide: 2015 [J].
Therrell, Bradford L. ;
Padilla, Carmencita David ;
Loeber, J. Gerard ;
Kneisser, Issam ;
Saadallah, Amal ;
Borrajo, Gustavo J. C. ;
Adams, John .
SEMINARS IN PERINATOLOGY, 2015, 39 (03) :171-187
[10]   Neonatal screening for profound biotinidase deficiency in the Netherlands: consequences and considerations [J].
Wiltink, Rachel C. ;
Kruijshaar, Michelle E. ;
van Minkelen, Rick ;
Onkenhout, Willem ;
Verheijen, Frans W. ;
Kemper, Evelien A. ;
van Spronsen, Francjan J. ;
van der Ploeg, Ans T. ;
Niezen-Koning, Klary E. ;
Saris, Jasper J. ;
Williams, Monique .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2016, 24 (10) :1424-1429